Litigation Details for Valeant Pharmaceuticals North America LLC v. PAR Pharmaceutical, Inc. (S.D.N.Y. 2018)
✉ Email this page to a colleague
Valeant Pharmaceuticals North America LLC v. PAR Pharmaceutical, Inc. (S.D.N.Y. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-09-10 |
| Court | District Court, S.D. New York | Date Terminated | 2018-12-09 |
| Cause | 35:271 Patent Infringement | Assigned To | Edgardo Ramos |
| Jury Demand | None | Referred To | |
| Patents | 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Valeant Pharmaceuticals North America LLC v. PAR Pharmaceutical, Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Valeant Pharmaceuticals North America LLC v. PAR Pharmaceutical, Inc. (S.D.N.Y. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-12-09 | 18 | Notice of Voluntary Dismissal - Signed | Paragraph IV certifications as to U.S. Patent Nos. 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,… 10 December 2018 1:18-cv-08221 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
